
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT
- About
Beauty Health Co (SKIN)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/15/2025: SKIN (1-star) has a low Upturn Star Rating. Not recommended to BUY.
1 Year Target Price $1.88
1 Year Target Price $1.88
0 | Strong Buy |
0 | Buy |
7 | Hold |
2 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -30.26% | Avg. Invested days 24 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 320.87M USD | Price to earnings Ratio - | 1Y Target Price 1.88 |
Price to earnings Ratio - | 1Y Target Price 1.88 | ||
Volume (30-day avg) 9 | Beta 1.23 | 52 Weeks Range 0.78 - 2.64 | Updated Date 09/15/2025 |
52 Weeks Range 0.78 - 2.64 | Updated Date 09/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.18 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -6.13% | Operating Margin (TTM) -3.45% |
Management Effectiveness
Return on Assets (TTM) -4.45% | Return on Equity (TTM) -26.55% |
Valuation
Trailing PE - | Forward PE 106.38 | Enterprise Value 485599254 | Price to Sales(TTM) 1.03 |
Enterprise Value 485599254 | Price to Sales(TTM) 1.03 | ||
Enterprise Value to Revenue 1.57 | Enterprise Value to EBITDA 23.45 | Shares Outstanding 126825000 | Shares Floating 81549999 |
Shares Outstanding 126825000 | Shares Floating 81549999 | ||
Percent Insiders 9.98 | Percent Institutions 86.12 |
Upturn AI SWOT
Beauty Health Co
Company Overview
History and Background
Beauty Health Co. was founded in 2006 and is known for its flagship product, the HydraFacial system. It went public via a SPAC merger with Vesper Healthcare Acquisition Corp in May 2021.
Core Business Areas
- Skincare Systems: Development, manufacturing, and marketing of the HydraFacial system and related consumables.
- Consumables: Sale of treatment serums, tips, and other related products used with the HydraFacial system.
Leadership and Structure
Andrew Stanleick serves as President and CEO. The company has a board of directors overseeing its operations.
Top Products and Market Share
Key Offerings
- HydraFacial: A non-invasive skin resurfacing treatment that cleanses, exfoliates, extracts, and hydrates the skin. Competitors include microdermabrasion devices and chemical peels. Market share data is difficult to precisely quantify, but HydraFacial maintains a leading position in the aesthetic treatment market. The company estimates the HydraFacial system has served millions of treatments globally and revenue is largely driven by this product.
- Consumables & Skincare: Solutions, serums, and ancillary products used with the HydraFacial device, as well as skincare for home use. Competitors include skincare brands like SkinCeuticals, Obagi, and PCA Skin.
Market Dynamics
Industry Overview
The aesthetics market is growing, driven by increasing consumer interest in skincare and non-invasive treatments. Technology advancements and product innovation are key factors.
Positioning
Beauty Health Co. positions itself as a leader in the aesthetic treatment market with its innovative HydraFacial technology. Its competitive advantages include brand recognition and a global footprint.
Total Addressable Market (TAM)
Estimates for the global aesthetic market vary, but reach hundreds of billions of dollars. HydraFacial is well positioned to capture a significant share of this TAM.
Upturn SWOT Analysis
Strengths
- Strong brand recognition (HydraFacial)
- Global distribution network
- Recurring revenue stream from consumables
- Innovative technology
Weaknesses
- High reliance on a single product (HydraFacial)
- Exposure to economic cycles affecting consumer spending
- Intense competition
- High Marketing Costs
Opportunities
- Expansion into new markets
- Development of new products and services
- Strategic partnerships and acquisitions
- Increased demand for non-invasive aesthetic treatments
Threats
- Economic downturn
- Increased competition
- Technological obsolescence
- Changes in consumer preferences
Competitors and Market Share
Key Competitors
- SYND
- ALGN
- LULU
- CNMD
Competitive Landscape
Beauty Health Co. benefits from a strong brand and established position but faces competition from larger, more diversified companies and new entrants.
Growth Trajectory and Initiatives
Historical Growth: Beauty Health Co. has shown revenue growth driven by increased HydraFacial system placements and consumables sales.
Future Projections: Analyst estimates for future growth vary and depend on market conditions and company performance.
Recent Initiatives: Focus on global expansion and new product development.
Summary
Beauty Health Co. has a strong brand with its HydraFacial system, driving revenue through device sales and recurring consumables. However, the company relies heavily on one product and faces strong competition. Future success depends on diversifying its product line and managing its cost structure. Economic downturns could impact consumer spending and hurt the company.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings (10-K, 10-Q)
- Company Investor Relations
- Third-party market research reports
- Financial News Outlets
Disclaimers:
The data and analysis provided are for informational purposes only and should not be considered financial advice. Actual results may vary. Market share percentages are estimates and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Beauty Health Co
Exchange NASDAQ | Headquaters Long Beach, CA, United States | ||
IPO Launch date 2020-11-24 | President, CEO & Director Ms. Marla Malcolm Beck | ||
Sector Consumer Defensive | Industry Household & Personal Products | Full time employees 769 | Website https://www.beautyhealth.com |
Full time employees 769 | Website https://www.beautyhealth.com |
The Beauty Health Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells esthetic technologies and products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers. The Beauty Health Company was founded in 1997 and is headquartered in Long Beach, California.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.